NCT00640276View on ClinicalTrials.gov

Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

February 28, 2011

Study Completion Date

June 30, 2011

Conditions
HypercholesterolemiaMetabolic Syndrome
Interventions
DRUG

pitavastatin

Pitavastatin 2mg daily once

BEHAVIORAL

Lifestyle Modification

conducting mainly exercises and diet

Trial Locations (2)

463-707

Seoul National University Bundang Hospital, Bundang-gu

471-701

Hanyang Univ. Guri Hospital, Guri-si

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY

NCT00640276 - Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome | Biotech Hunter | Biotech Hunter